We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas

This study has suspended participant recruitment.
(Funding)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01723306
First Posted: November 7, 2012
Last Update Posted: June 14, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Richard Junghans, PhD, MD, Roger Williams Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: August 2017
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)